Symbol | Exchange | Currency |
|---|
March 10 (Reuters) - Carnegie Clean Energy Ltd CCE.AX :* CARNEGIE CLEAN ENERGY LTD - ANNOUNCE DEBT REDUCTION FOLLOWING CONVERSION OF $1.75 MILLION OF CONVERTIBLE NOTES INTO SHARES...
Jan 7 (Reuters) - Carnegie Clean Energy Ltd CCE.AX :* GARDEN ISLAND MICROGRID HAS RESUMED NORMAL OPERATIONS AFTER TEMPORARY DISCONNECTION
Nov 30 (Reuters) - Carnegie Clean Energy Ltd CCE.AX :* SIGNED A COLLABORATION AGREEMENT WITH HEWLETT PACKARD ENTERPRISE COMPANY
Government dithering at the state and federal levels is hurting the renewable energy sector, with the net result being greater investment uncertainty, according to a panel at the...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Strong Buy | Strong Buy | Strong Sell |
| Technical Indicators | Sell | Sell | Buy | Neutral | Sell |
| Summary | Sell | Sell | Strong Buy | Buy | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 15.96 | 16.06 | 15.81 | +0.29 | +1.88% | 347.31K | Sydney | |||
| 6.51 | 6.57 | 6.50 | +0.050 | +0.77% | 1.86M | Sydney | |||
| 25.91 | 26.10 | 25.84 | -0.030 | -0.12% | 1.13M | Sydney | |||
| 2.16 | 2.20 | 2.14 | -0.01 | -0.46% | 456.89K | Sydney | |||
| 1.442 | 1.485 | 1.428 | -0.043 | -2.86% | 7.12M | Sydney | |||
| 6.85 | 6.94 | 6.69 | +0.05 | +0.74% | 4.56M | Sydney | |||
| 22.35 | 22.42 | 22.12 | +0.300 | +1.36% | 837.90K | Sydney | |||
| 2.90 | 2.95 | 2.86 | +0.06 | +2.11% | 92.11K | Sydney | |||
| 102.34 | 103.86 | 101.50 | -2.09 | -2.00% | 404.42K | Sydney | |||
| 24.68 | 24.72 | 24.57 | +0.060 | +0.24% | 1.29M | Sydney | |||
| 1.415 | 1.415 | 1.405 | +0.005 | +0.35% | 396.48K | Sydney | |||
| 7.04 | 7.20 | 6.99 | -0.070 | -0.98% | 6.67M | Sydney | |||
| 7.95 | 8.20 | 7.94 | +0.11 | +1.40% | 1.32M | Sydney | |||
| 99.00 | 99.00 | 97.70 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 9.44 | 9.52 | 9.36 | -0.08 | -0.84% | 50.68K | Sydney |
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company’s patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient’s own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient’s own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.
